Best Acute lymphoblastic leukemia doctors: TOP 74 doctors

• Prof. MD Zafer Gulbas specializes in acute lymphoblastic leukemia (ALL) treatment and bone marrow transplantation.
• ALL treatment methods include chemotherapy, targeted therapy, immunotherapy, and bone marrow transplantation.
• International training at medical institutions in Israel, USA (Fred Hutchinson, M.D. Anderson), and Canada (Princess Margaret Hospital).
• Director of the Bone Marrow Transplantation Center at Anadolu Medical Center since 2005.
• Professional memberships: Turkish Society of Hematology, European Hematology Association, and American Society of Hematology.

• Specializes in acute lymphoblastic leukemia (ALL) treatment, including chemotherapy, targeted therapy, and immunotherapy.
• Has international practice experience at medical institutions in the USA, UK, Israel, and Turkey.
• Certified by the European Society of Medical Oncology (ESMO), ensuring high standards in oncology care.
• Member of ESMO and European School of Oncology (ESO), reflecting her commitment to ongoing education.
• Fluent in English and Turkish, with intermediate proficiency in Russian, which aids in patient communication.

• Specializes in treating Acute Lymphoblastic Leukemia (ALL) with tailored therapies.
• Employs chemotherapy, stem cell transplant, and targeted therapy for ALL.
• Trained in Japan, contributing to international expertise in hematology.
• Accumulated hands-on experience in one of Turkey's largest BMT units.
• Proficient in English and Turkish, facilitating multilingual consultations.
• Offers remote consultations for patients with Acute Lymphoblastic Leukemia.
• Over 26 years of experience in Hematology, focusing on bone marrow transplantation.

Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

• Dr. Bertram Glaß specializes in Acute Lymphoblastic Leukemia (ALL) treatment.
• Expert in chemotherapy, targeted therapy, and bone marrow transplantation for ALL.
• Oversees stem cell transplant unit at Helios Berlin-Buch, critical for ALL care.
• International practice includes Germany, contributing to global oncology research.
• Participates in clinical trials for advancing ALL treatment methodologies.
• Member of top oncological societies like ASCO and ESMO, ensuring up-to-date care.
• Fluent in German with comprehensive care offered to native speakers.

Dr. Girish V. Badarkhe is an experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with MBBS, MD, and DM degrees. He has 13+ years of expertise in leukemia, multiple myeloma, and bone marrow transplant, and has received awards for his professional and hard work.

• Dr. Jaume Mora Graupera specializes in the treatment of acute lymphoblastic leukemia (ALL) in children.
• He utilizes chemotherapy, targeted therapy, immunotherapy, stem cell transplant, and CAR-T cell therapy.
• Dr. Mora Graupera trained in pediatric hematology oncology at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA.
• He is the Director of the Hematology Oncology Department at Sant Joan De Déu - Barcelona Children’s Hospital.
• He is a member of the International Society of Pediatric Oncology and the American Society of Clinical Oncology.

Professor Fabio Ciceri is the Head of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. He has over 180 papers published and has held various Medical and Teaching positions since 1989. He is a member of multiple organizations related to Hematology and was awarded a Merit Recognition Award at the University of Ferrara. He is a Principal Investigator in Cell and Gene Therapy clinical trials for haematological cancers, immune-deficiencies, and neuromuscular disorder.

• Prof. Elke Jaeger specializes in acute lymphoblastic leukemia (ALL) treatment, leading the Oncology and Hematology Center at Nordwest.
• She utilizes chemotherapy, targeted therapy, immunotherapy, stem cell transplantation, and CAR T-cell therapy for ALL management.
• She has international training and practice experience at medical institutions in Germany, contributing to her proficiency in advanced leukemia treatments.
• Recognized as one of the best German oncologists by Focus rating, reflecting her excellence in patient care.
• With over 35 years of experience, she provides comprehensive and cutting-edge treatment for patients with ALL.

Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.

Head of the Hematology, Oncology and Bone Marrow Transplantation Department

• Dr. Jorg Groticke specializes in Acute lymphoblastic leukemia treatment.
• Utilizes chemotherapy, targeted therapy, and stem cell transplants.
• International practice in Germany, with global recognition.
• Holds a degree in immunology, contributing to cancer treatment proficiency.
• Member of German Society of Hematology and Oncology, enhancing treatment strategies.
• Offers remote consultations for Acute lymphoblastic leukemia patients worldwide.
• Fluent in the German language for effective communication.

Pediatric hematologist-oncologist, bone marrow transplant specialist

• Dr. Eckhart Weidemann specializes in the treatment of acute lymphoblastic leukemia with over 30 years of experience.
• He heads the Hematology sector at Nordwest Clinic, focusing on blood disorder treatments.
• Standard treatment options for acute lymphoblastic leukemia include chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation.
• Dr. Weidemann has international experience, having practiced at clinics in Germany and Switzerland.
• He holds certifications from the European Hematology Association and is a member of the American Society of Hematology.

Dr. Jacopo Peccatori is the Head of Bone Marrow Transplant Department in San Raffaele Scientific Institute and one of the top lymphoma doctors. He has been in this position since 2006 and has written over 70 studies on allogeneic bone marrow transplantation, acute leukemia, and multiple myeloma. He has a degree in general medicine from the University of Milan and specialties in internal medicine and haematology and is a member of The European Society for Blood and Marrow Transplantation and The Italian Group for Hematopoietic Stem Cell Transplantation and Cell Therapies.

• Children's Hematologist specializing in acute lymphoblastic leukemia (ALL) treatment and bone marrow transplantation.
• Expert in chemotherapy, targeted therapy, immunotherapy, and bone marrow transplantation for ALL.
• International training at clinics in Spain, the United States, and the United Kingdom.
• Member of the European Society for Paediatric Haematology and Immunology (ESPHI).
• Fluent in English and Spanish, enabling effective communication with patients from diverse backgrounds.